Glaukos Corporation $GKOS reported second-quarter 2026 revenue of $185.6 million, up 49.5% from a year earlier and ahead of Wall Street expectations. Gross profit climbed to $151.6 million, reflecting strong top-line growth and improved sales momentum.
Despite the stronger revenue performance, the company remained in the red. Operating loss was $17.3 million, while net loss attributable to common shareholders came to $18.4 million, or -$0.31 per diluted share. That was wider than analysts expected on the EPS line, but better than the prior-year operating and net loss comparisons.
Key balance sheet and cash flow items showed a mixed picture:
The shares rose 1.93% after the market close, suggesting investors focused on the company’s faster-than-expected revenue growth even as profitability remained under pressure.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Glaukos Corporation Insider Trading Activity
Glaukos Corporation insiders have traded $GKOS stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $GKOS stock by insiders over the last 6 months:
- ALEX R. THURMAN (SVP & CHIEF FINANCIAL OFFICER) has made 0 purchases and 7 sales selling 44,657 shares for an estimated $6,539,359.
- JOSEPH E GILLIAM (PRESIDENT & COO) sold 19,573 shares for an estimated $2,809,508
- AIMEE S WEISNER has made 0 purchases and 4 sales selling 15,000 shares for an estimated $1,760,761.
- GILBERT H KLIMAN has made 0 purchases and 2 sales selling 10,000 shares for an estimated $1,378,800.
- TOMAS NAVRATIL (CHIEF DEVELOPMENT OFFICER) has made 0 purchases and 9 sales selling 5,377 shares for an estimated $647,675.
- LEANA WEN sold 1,700 shares for an estimated $243,695
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Glaukos Corporation Hedge Fund Activity
We have seen 150 institutional investors add shares of Glaukos Corporation stock to their portfolio, and 152 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 1,419,970 shares (+5267.7%) to their portfolio in Q1 2026, for an estimated $152,873,970
- DRIEHAUS CAPITAL MANAGEMENT LLC added 487,912 shares (+inf%) to their portfolio in Q1 2026, for an estimated $52,528,605
- UBS GROUP AG removed 487,542 shares (-55.8%) from their portfolio in Q1 2026, for an estimated $52,488,771
- JENNISON ASSOCIATES LLC added 487,020 shares (+inf%) to their portfolio in Q1 2026, for an estimated $52,432,573
- WESTFIELD CAPITAL MANAGEMENT CO LP added 482,219 shares (+inf%) to their portfolio in Q1 2026, for an estimated $51,915,697
- MILLENNIUM MANAGEMENT LLC removed 436,003 shares (-27.1%) from their portfolio in Q1 2026, for an estimated $46,940,082
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. added 416,231 shares (+inf%) to their portfolio in Q2 2026, for an estimated $58,172,444
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Glaukos Corporation Government Contracts
We have seen $201,070 of award payments to $GKOS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TRAVOPROST 75MCG: $169,104
- IDOSE TRAVOPROST 75MCG IMPLANT: $21,310
- IDOSE TR 75 MGC IMPLANT: $10,655
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
Glaukos Corporation Analyst Ratings
Wall Street analysts have issued reports on $GKOS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 06/10/2026
To track analyst ratings and price targets for Glaukos Corporation, check out Quiver Quantitative's $GKOS forecast page.
Glaukos Corporation Price Targets
Multiple analysts have issued price targets for $GKOS recently. We have seen 7 analysts offer price targets for $GKOS in the last 6 months, with a median target of $162.0.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $175.0 on 07/08/2026
- Yi Chen from HC Wainwright & Co. set a target price of $168.0 on 07/06/2026
- Adam Maeder from Piper Sandler set a target price of $165.0 on 07/01/2026
- David Saxon from Needham set a target price of $150.0 on 06/17/2026
- Ryan Zimmerman from BTIG set a target price of $162.0 on 06/10/2026
- Larry Biegelsen from Wells Fargo set a target price of $138.0 on 04/30/2026
- Allen Gong from JP Morgan set a target price of $140.0 on 04/30/2026
